BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Albors-Vaquer A, Rizvi A, Matzapetakis M, Lamosa P, Coelho AV, Patel AB, Mande SC, Gaddam S, Pineda-Lucena A, Banerjee S, Puchades-Carrasco L. Active and prospective latent tuberculosis are associated with different metabolomic profiles: clinical potential for the identification of rapid and non-invasive biomarkers. Emerg Microbes Infect 2020;9:1131-9. [PMID: 32486916 DOI: 10.1080/22221751.2020.1760734] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 5.0] [Reference Citation Analysis]
Number Citing Articles
1 Foster M, Hill PC, Setiabudiawan TP, Koeken VACM, Alisjahbana B, van Crevel R. BCG-induced protection against Mycobacterium tuberculosis infection: Evidence, mechanisms, and implications for next-generation vaccines. Immunol Rev 2021;301:122-44. [PMID: 33709421 DOI: 10.1111/imr.12965] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
2 Gómez-Cebrián N, García-Flores M, Rubio-Briones J, López-Guerrero JA, Pineda-Lucena A, Puchades-Carrasco L. Targeted Metabolomics Analyses Reveal Specific Metabolic Alterations in High-Grade Prostate Cancer Patients. J Proteome Res 2020;19:4082-92. [PMID: 32924497 DOI: 10.1021/acs.jproteome.0c00493] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
3 Luo Y, Xue Y, Mao L, Lin Q, Tang G, Song H, Liu W, Tong S, Hou H, Huang M, Ouyang R, Wang F, Sun Z. Activation Phenotype of Mycobacterium tuberculosis-Specific CD4+ T Cells Promoting the Discrimination Between Active Tuberculosis and Latent Tuberculosis Infection. Front Immunol 2021;12:721013. [PMID: 34512645 DOI: 10.3389/fimmu.2021.721013] [Reference Citation Analysis]
4 Jiang J, Li Z, Chen C, Jiang W, Xu B, Zhao Q. Metabolomics Strategy Assisted by Transcriptomics Analysis to Identify Potential Biomarkers Associated with Tuberculosis. Infect Drug Resist 2021;14:4795-807. [PMID: 34815677 DOI: 10.2147/IDR.S330493] [Reference Citation Analysis]
5 Liebenberg C, Luies L, Williams AA. Metabolomics as a Tool to Investigate HIV/TB Co-Infection. Front Mol Biosci 2021;8:692823. [PMID: 34746228 DOI: 10.3389/fmolb.2021.692823] [Reference Citation Analysis]
6 Jiang H, Li L, Chen W, Chen B, Li H, Wang S, Wang M, Luo Y. Application of Metabolomics to Identify Potential Biomarkers for the Early Diagnosis of Coronary Heart Disease. Front Physiol 2021;12:775135. [PMID: 34912241 DOI: 10.3389/fphys.2021.775135] [Reference Citation Analysis]
7 Li ZT, Zeng PY, Chen ZM, Guan WJ, Wang T, Lin Y, Li SQ, Zhang ZJ, Zhan YQ, Wang MD, Tan GB, Li X, Ye F. Exhaled Volatile Organic Compounds for Identifying Patients With Chronic Pulmonary Aspergillosis. Front Med (Lausanne) 2021;8:720119. [PMID: 34631744 DOI: 10.3389/fmed.2021.720119] [Reference Citation Analysis]
8 Luo Y, Xue Y, Tang G, Cai Y, Yuan X, Lin Q, Song H, Liu W, Mao L, Zhou Y, Chen Z, Zhu Y, Liu W, Wu S, Wang F, Sun Z. Lymphocyte-Related Immunological Indicators for Stratifying Mycobacterium tuberculosis Infection. Front Immunol 2021;12:658843. [PMID: 34276653 DOI: 10.3389/fimmu.2021.658843] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
9 Conde R, Laires R, Gonçalves LG, Rizvi A, Barroso C, Villar M, Macedo R, Simões MJ, Gaddam S, Lamosa P, Puchades-Carrasco L, Pineda-Lucena A, Patel AB, Mande SC, Barnejee S, Matzapetakis M, Coelho AV. Discovery of serum biomarkers for diagnosis of tuberculosis by NMR metabolomics including cross-validation with a second cohort. Biomed J 2021:S2319-4170(21)00094-9. [PMID: 34314900 DOI: 10.1016/j.bj.2021.07.006] [Reference Citation Analysis]